ARCHIVES

Nancy Brinker Resigns As CEO of Komen

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

Bethesda System Revised For Reporting Pap Test Results

April 26, 2002

Concepts for New, Recompeted DCCP Contracts Approved

June 12, 1981

In Brief: Schweitzer ACS President, Dodd President Elect, FDA Commissioner Resigns Abruptly

November 17, 1989

DCT Board Committee Recommends Limited Start On In Vitro Screening Program

January 18, 1985

NIH Grants: R29 Awards No Longer Accepted After June; NIH To Increase R01s.

December 5, 1997

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

November 27, 2009